Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients With Advanced Glaucoma

NCT02526680 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT02526680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of a Novel Artificial Vision Device (OrCam) on the Quality of Life of Patients With Advanced Glaucoma
Lead sponsor
Wills Eye
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
August 31, 2015
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma